T he rising rate of cardiovascular implantable electronic device (CIED) infection (permanent pacemaker and implantable cardioverter-defibrillator [ICD]) has been strikingly out of proportion to that of device implantation. [1] [2] [3] [4] Analysis of clinical factors associated with short-and longterm mortality among patients with CIEDs showed that CIED infection was a strong predictor of death. 1,5 Aging of the population and increases in implant volumes will further amplify the problem of CIED-related infections in the future. In addition, financial costs associated with ICD infection can be significant, with an average length of stay for CIED infection from 8 to 20 days and total costs from $24 000 to $130 000. 3, 4, [6] [7] [8] 
Patient Population
Merged Registry and MedPAR claims data from 2006 to 2009 were used to identify patients with ICD infection after initial hospital discharge, as previously described. [12] [13] [14] Briefly, deterministic matching of the Registry and MedPAR claims files was performed using indirect patient identifiers (age, sex, admission date, ICD procedure date, provider number) found in both datasets. Using this approach, 70% of Medicare patients have been liked with Registry files.
Patients were initially identified if they had a principal or secondary diagnosis indicating CIED infection (ICD-9-CM code 996.6 or 996.61) or infective endocarditis (either a diagnosis related group for endocarditis [126] or a principal or secondary diagnosis indicating infective endocarditis [ICD-9-CM codes 421.0, 421.1, 421.9]). In addition, patients were included if they had both a procedural code for initial ICD/cardiac resynchronization therapy implant (3794, 3795, 3796, 3797, 3798, 0051, 0052), pacemaker or ICD/cardiac resynchronization therapy removal (3789, 3794, 3795, 3796, 3797, 3798, 0051, 0052), or lead removal (3777) as well as having an ICD-9-CM codes for sepsis (038, 785.52, 785.59), bacteremia (790.7), endocarditis (421.0, 421.1, 421.9, 424.90, 424.91), cellulitis (681.00, 681.1, 682), or fever (780.6) during the same admission. 5 Subjects were excluded if the index procedure in the Registry was a reimplant for device infection, if the implanted ICD type was not known, or if the patient died during the index hospitalization.
Potential Risk Factors
Potential risk variables evaluated included demographic factors, clinical characteristics, procedure-related events, and operator and hospital factors available in the Registry. These included age at implantation, gender, race, previous syncope, family history of sudden death, previous heart failure hospitalization, New York Heart Association (NYHA) class, atrial fibrillation/flutter, history of ventricular tachycardia, sinus node dysfunction, nonischemic cardiomyopathy, ischemic heart disease, previous percutaneous coronary interventional, valvular or coronary artery bypass graft surgery, cerebrovascular disease, chronic lung disease, diabetes mellitus, hypertension, renal failure on dialysis, blood urea nitrogen and creatinine levels, sodium level, systolic blood pressure, use of warfarin, aspirin, clopidogrel, and ticlopidine, intraventricular conduction abnormalities, QRS duration, ejection fraction, ICD generator replacement versus initial implant, type of ICD, adverse events during implantation, operator training and volume, hospital teaching status, and hospital coronary artery bypass graft and coronary catheterization availability.
Statistical Analysis
The patient demographic factors, clinical characteristics, procedurerelated events, discharge medications, and operator and hospital factors were compared between patients with and without ICD infection. The χ 2 test and t test were used for categorical variables and continuous variables, respectively. The specific adverse events during or after the implant procedure until discharge between ICD infection patients and ICD noninfection patients were examined by χ 2 or Fisher's exact tests. The Kaplan-Meier curve of ICD infection was used to show the survival function of ICD infection within 6 months of ICD implantation. The missing rates of variables were <0.5% except for ejection fraction percent (4%), hospital beds set up (2.6%), hospital teaching status (2.6%), cardiac facility (2.6%), and operator type (22%). Multiple imputation technique was used for the missing values. Then, a hierarchical logistic regression model was used to examine patient, operator, and hospital factors associated with risk of ICD infection. The model accounted for clustering of the patients within hospitals through the inclusion of a hospital-specific random effect. Because of the multiple comparisons used, a P value <0.0012 (P=0.05/42 variables) was considered statistically significant. All analyses were performed on SAS Version 9.3.
Results
Using the indirect patient matching method, 204 309 ICDs were implanted between 2006 to 2009 and had CMS claims data available. Of these, 2197 had a reimplant for device infection, 276 had a missing ICD type, and 927 had inhospital death, all of which were excluded. The remaining 200 909 implanted ICDs from 1348 hospitals were included in the analysis.
A total of 3390 (1.7%) infections were observed through 6 months. Infections were more frequent in the first 45 days, but continued throughout the entire 6 months ( Figure) . Baseline characteristics are shown in Table 1 . Patients who developed an ICD infection were more likely to have several medical comorbidities, including heart failure hospitalization, NYHA class III or IV, atrial fibrillation, abnormal sinus node function, prior ICD, previous coronary artery bypass graft or valvular surgery, cerebrovascular disease, chronic lung disease, diabetes mellitus, renal failure on dialysis, higher creatinine and blood urea nitrogen, abnormal intraventricular conduction with a wider QRS duration, lower ejection fraction, lower sodium level, and use of warfarin. In addition, they were less likely to have nonischemic dilated cardiomyopathy.
Patients with a cardiac resynchronization therapy/ICD device were more likely to develop infection than patients with dual-or single-chamber devices (2.0% versus 1.5% versus 1.4%, respectively, P<0.0001). Infection rates were higher regardless of whether the left ventricular lead was placed transvenously in the coronary sinus or epicardially. The infection rate was also higher if the most recent procedure was a device upgrade or battery change, versus initial implant (1.9% versus 1.6%, P<0.0001).
Several operator and hospital factors were also associated with infection, including nonelectrophysiology trained operators, those with lower implant volume, implant at a nonteaching hospital, and a hospital that did not perform coronary artery bypass graft surgery.
Those with an ICD infection were significantly more likely to have had an adverse event at the time of the most recent procedure (5.4% versus 1.9%, P<0.001). When examining specific adverse events, hematoma and lead dislodgement requiring early reoperation were significantly associated with future device infection ( Table 2) .
On multivariate analysis, factors found to be significantly associated with the development of ICD infection included adverse event during implant requiring reintervention, previous valvular surgery, reimplantation for device upgrade, malfunction, or manufacturer advisory, renal failure on dialysis, chronic lung disease, cerebrovascular disease, and warfarin use ( Table 3) . Because 1.47% of patients received >1 implant during the time period, we conducted a sensitivity analysis whereby 1 implant was randomly selected and combined with those patients who had only 1 implant. These results were not significantly different than the main analysis.
The 6-month mortality was 12.0% in those with ICD infection and 6.5% in those without (P<0.0001).
Discussion
In this study, the largest of ICD infections in Medicare patients, we have shown the 6-month rate of ICD infection after the last procedure was 1.7%. Infection rates were higher if there was a periprocedural adverse event, previous valve surgery, reimplantation for device upgrade, malfunction, or manufacturer advisory, and increased comorbidities.
Previous studies have reported infection rates in a similar range. Although small studies have suggested an infection rate of 0.03 to 7.9%, 15 multicenter registries have had rates of 0.3 to 2.2%. 7,16-21 A retrospective analysis of Medicare data from 2002 to 2005 examined 8581 patients undergoing ICD implantation. 22 The infection rate was 0.7% during the index hospitalization, 1.6% at 30 days, and 2.2% at 90 days. Using the Nationwide Inpatient Sample, which reports on ≈20% of all inpatient hospitals, the rate of ICD and pacemaker infection was 1.61% between 1993 and 2008. 4 From 2006 to 2008, which is similar to our time period, there was an increase in infection rate from 1.7% to 2.4%. Variability in these studies may be attributable to differences in patient comorbidities, duration of follow-up, inclusion of pacemakers as well as ICDs, presence of epicardial systems or abdominal generators, or different definitions of infection.
Postoperative complications, especially hematoma, have been seen in several studies as a risk factor. 19, [23] [24] [25] Hematoma is only defined in the Registry if the patient required reoperation or transfusion. Because lead dislodgement was also a risk factor, it is probable that early reoperation is the most important risk factor for ICD infection. The exact reason for this is not clear. Several studies have demonstrated that a lead addition or generator change, including re-entering for manufacturer advisory, leads to a higher risk of infection compared with initial implantation. 7, 19, 20, 23, [25] [26] [27] [28] [29] [30] It is thought that bacteria can colonize a pocket after initial implantation but do not lead to clinical infection, as they are in equilibrium with the host immune response. 31 Disrupting the pocket with a redo procedure may affect the interaction between the organism and host, leading to a CIED infection. In fact, several studies have demonstrated up to a 42% presence of bacteria cultured from asymptomatic pockets at the time of generator change. 32, 33 Re-entering a pocket for other reasons such as device upgrade, malfunction, and manufacturer advisory was a risk factor, whereas re-entering for a battery change was not, suggesting a possible time-dependence influence on infection risk.
In addition, hematomas may also influence risk because they impair wound healing or lead to wound dehiscence, or because the presence of blood in the pocket is conducive to bacterial growth. Warfarin use was associated with an increase risk, as seen in some previous studies, 20 though not all. 19, 23, 27 Warfarin may have increased the number of hematomas that did not require reintervention, which would not be counted as an adverse event in our study.
Similar to previous studies, renal dysfunction, especially hemodialysis, was a potent risk factor in our study. 4, 20, 23, 34 Not only is there altered immunity in those with kidney disease on hemodialysis, but patients have frequent vascular access, indwelling catheters, and increased risk of bacteremia. 35, 36 Previous valve surgery increases risk of ICD infection because there is a 50-fold higher rate of endocarditis in those with prosthetic valves compared with native valves. 37 If there is a valvular vegetation, especially with Staphylococcus aureus or fungi, the ICD is thought to be infected also even if no vegetation is seen on the ICD leads. 38 That said, not all have found that prosthetic valves increases risk of ICD infection. 29, 39 One study showed a correlation of an increase in respiratory failure with CIED infection but no multivariate analysis was completed, 4 whereas another did not find this. 39 Cerebrovascular disease appears to be a novel risk factor for ICD infection. It is unlikely that these are directly causative but more likely reflects unknown or unmeasured associated factors.
The c-statistic for the multivariable model, even though it included a large number of predictive variables, was quite poor. The patient, operator, and hospital characteristics which were examined represented variables that have previously been examined, as well as novel factors. Other studies that have used multivariable models have not included the c-statistic, so direct comparison of model strengths cannot be completed. 19, 23, 27, 29, 34, 39, 40 Regardless, even with a large number of patients and predictive variables, this study suggests that there are important unknown clinical and patient characteristics that influence ICD infection.
Limitations
The main limitation of this study is the use of administrative coding to define ICD infections, because we could not validate diagnoses with chart review. Several studies have used ICD-9 codes and administrative databases, including MedPAR and the National Hospital Discharge Survey, to look at CIED infections. 1, 2, 4, 6, 41, 42 As noted by other investigators, 2, 41 although the practice of coding for complications of CIEDs may be subject to bias, it is more likely that there is undercoding versus overcoding, and it is likely that any undercoding would be random and not prone to bias in any 1 direction. Undercoding would also lead to an underestimation of the true risk of infection.
The data regarding infection risk of devices are predominantly affected by the duration of follow-up in studies. We have only been able to determine the 6-month rate of ICD infection, and the true incidence over the lifetime of a Medicare beneficiary is unknown.
In addition, the information obtained from this study is only applicable to the Medicare population and may not be valid in other patient groups (ie, younger patients, private insurance, etc). Because of the large sample size, some variables may be statistically significant, but may actually be surrogates for other variables that could not be tested in this study because of lack of available information in the Registry. We could not assess several factors seen in previous studies, such as use of skin cleansing agent, antibiotics in solution used to irrigate the ICD pocket, fever within 24 hours of implant, use of a temporary pacing wire, presence of a central venous catheter, abdominal versus pectoral generator, and procedure duration. 16, 19, 23, 41, 43 Similarly, other potentially relevant variables could not be assessed, such as open pocket time, removal of the ICD capsule at the time of generator change, or duration of postprocedural antibiotics.
Conclusion
Merging ICD Registry and Medicare data in >200 000 patients, we demonstrated an overall ICD infection rate of 1.7% within 6 months. The presence of an adverse event, especially where there was early reoperation for hematoma or lead dislodgement, greatly increased the rate of infection. In addition, reentering an ICD pocket for an upgrade, manufacturer advisory, or malfunction also increased infection rates. Efforts should be made to prevent the need for early reintervention during the peri-implant time period and carefully consider when to re-enter the pocket for reasons other than battery replacement.
Sources of Funding
The study was partially funded by a grant from the American Heart Association to Dr Uslan. In addition, this research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR).
Disclosures
Dr Reynolds has received consulting fees from Medtronic. Dr Curtis has received salary support under contract with the American College of Cardiology (ACC) to provide data analytic services for the ICD registry and has significant stock holdings in Medtronic, a maker of ICDs. The other authors report no conflicts. The views expressed in this manuscript represent those of the authors, and do not necessarily represent the official views of the NCDR or its associated professional societies identified at www.ncdr.com. The ICD Registry is an initiative of the American College of Cardiology Foundation and the Heart Rhythm Society.
